Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses

Journal of Virology

Volumn 79, Issue 11, 2005, Pages 7014-7023

  Chen, Zigui ^a   Terai, Masanori ^a,d   Fu, Leiping ^a   Herrero, Rolando ^b   DeSalle, Rob ^c   Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Proyecto Epidemiologico Guanacaste   (Costa Rica)

^c DIVISION OF INVERTEBRATE ZOOLOGY   (United States)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA;

ARTICLE; BASE PAIRING; CODON; CONTROLLED STUDY; FEMALE; GENOME ANALYSIS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MICROBIAL DIVERSITY; MOLECULAR EVOLUTION; OPEN READING FRAME; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; BASE SEQUENCE; CERVIX UTERI; CODON; DNA, VIRAL; FEMALE; GENOME, VIRAL; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; POLYMORPHISM, GENETIC; SELECTION (GENETICS); SEQUENCE HOMOLOGY, NUCLEIC ACID; VARIATION (GENETICS);

DARWINIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 18744391386     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.11.7014-7023.2005     Document Type: Article

References (77)

1. Andersson, S., M. Alemi, E. Rylander, A. Strand, B. Larsson, J. Sallstrom, and E. Wilander. 2000. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br. J. Cancer 83:307-310.
2. Anisimova, M., J. P. Bielawski, and Z. Yang. 2002. Accuracy and power of Bayes prediction of amino acid sites under positive selection. Mol. Biol. Evol. 19:950-958.
3. Bartholomew, J. S., S. N. Stacey, B. Coles, D. J. Burt, J. R. Arrand, and P. L. Stern. 1994. Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein. Eur. J. Immunol. 24:3175-3179.
4. Beckman, G., R. Birgander, A. Sjalander, N. Saha, P. A. Holmberg, A. Kivela, and L. Beckman. 1994. Is p53 polymorphism maintained by natural selection? Hum. Hered. 44:266-270.
5. Bernard, H. U., and D. Apt. 1994. Transcriptional control and cell type specificity of HPV gene expression. Arch. Dermatol. 130:210-215.
6. Berumen, J., R. M. Ordonez, E. Lazcano, J. Salmeron, S. C. Galvan, R. A. Estrada, E. Yunes, A. Garcia-Carranca, G. Gonzalez-Lira, and A. Madrigal-de la Campa. 2001. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 93:1325-1330.
7. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. Jansen, J. Peto, M. Schiffman, V. Moreno, R. Kurman, K. Shah, and I. S. Group. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
8. Brady, C. S., M. F. Duggan-Keen, J. A. Davidson, J. M. Varley, and P. L. Stern. 1999. Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters. J. Gen. Virol. 80:3233-3240.
9. Burk, R. D., G. Y. F. Ho, L. Beardsley, M. Lempa, M. Peters, and R. Bierman. 1996. Sexual practices and partner selection are the predominant risk factors for genital HPV infection in young women. J. Infect. Dis. 174:679-689.
10. Casas, L., S. C. Galvan, R. M. Ordonez, N. Lopez, M. Guido, and J. Berumen. 1999. Asian-American variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int. J. Cancer 83:449-455.
11. Chakrabarti, O., K. Veeraraghavalu, V. Tergaonkar, Y. Liu, E. J. Androphy, M. A. Stanley, and S. Krishna. 2004. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by Notch signaling and oncogenic Ras. J. Virol. 78:5934-5945.
12. Chan, S.-Y., L. Ho, C.-K. Ong, V. Chow, B. Drescher, M. Durst, J. ter Meulen, L. Villa, J. Luande, H. Mgaya, and H.-U. Bernard. 1992. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol. 66:2057-2066.
13. Chen, S. L., C. H. Huang, T. C. Tsai, K. Y. Lu, and Y. P. Tsao. 1996. The regulation mechanism of c-jun and junB by human papillomavirus type 16 E5 oncoprotein. Arch. Virol. 141:791-800.
14. Chen, S. L., Y. K. Lin, L. Y. Li, Y. P. Tsao, H. Y. Lo, W. B. Wang, and T. C. Tsai. 1996. E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element. J. Virol. 70:8558-8563.
15. Cheng, G., J. P. Icenogle, R. Kirnbauer, N. L. Hubbert, M. E. St. Louis, C. Han, E. I. Svare, S. K. Kjaer, D. R. Lowy, and J. T. Schiller. 1995. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J. Infect. Dis. 172:1584-1587.
16. Clifford, G. M., J. S. Smith, T. Aguado, and S. Franceschi. 2003. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 89:101-105.
17. Clifford, G. M., J. S. Smith, M. Plummer, N. Munoz, and S. Franceschi. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 88:63-73.
18. Cline, J., J. C. Braman, and H. H. Hogrefe. 1996. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. Nucleic Acids Res. 24:3546-3551.
19. Conrad, M., V. J. Bubb, and R. Schlegel. 1993. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67:6170-6178.
20. DeFilippis, V. R., F. J. Ayala, and L. P. Villarreal. 2002. Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes. J. Mol. Evol. 55:491-499.
21. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
22. Dillner, J. 1990. Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. Int. J. Cancer 46:703-711.
23. Ellis, J. R., P. J. Keating, J. Baird, E. F. Hounsell, D. V. Renouf, M. Rowe, D. Hopkins, M. F. Duggan-Keen, J. S. Bartholomew, L. S. Young, et al. 1995. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1:464-470.
24. Eriksson, A., J. R. Herron, T. Yamada, and C. M. Wheeler. 1999. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J. Gen. Virol. 80:595-600.
25. Fehrmann, F., D. J. Klumpp, and L. A. Laimins. 2003. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 77:2819-2831.
26. Gao, L., B. Chain, C. Sinclair, L. Crawford, J. Zhou, J. Morris, X. Zhu, and H. Stauss. 1994. Immune response to human papiliomavirus type 16 E6 gene in a live vaccinia vector. J. Gen. Virol. 75:157-164.
27. Genther, S. M., S. Sterling, S. Duensing, K. Munger, C. Sattler, and P. F. Lambert. 2003. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle. J. Virol. 77:2832-2842.
28. Giannoudis, A., and C. S. Herrington. 2001. Human papillomavirus variants and squamous neoplasia of the cervix. J. Pathol. 193:295-302.
29. Goldsborough, M. D., D. DiSilvestre, G. F. Temple, and A. T. Lorincz. 1989. Nucleotide sequence of human papillomavirus type 31: a cervical neoplasia-associated virus. Virology 171:306-311.
30. Herrero, R., A. Hildesheim, C. Bratti, M. E. Sherman, M. Hutchinson, J. Morales, I. Balmaceda, M. D. Greenberg, M. Alfaro, R. D. Burk, S. Wacholder, M. Plummer, and M. Schiffman. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92:464-474.
31. Hildesheim, A. 1997. Human papillomavirus variants: implications for natural history studies and vaccine development efforts. J. Natl. Cancer Inst. 89:752-753.
32. Hildesheim, A., M. Schiffman, C. Bromley, S. Wacholder, R. Herrero, A. Rodriguez, M. C. Bratti, M. E. Sherman, U. Scarpidis, Q. Q. Lin, M. Terai, R. L. Bromley, K. Buetow, R. J. Apple, and R. D. Burk. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl. Cancer Inst. 93:315-318.
33. Ho, G. Y. F., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
34. Ho, L., S. Y. Chan, R. D. Burk, B. C. Das, K. Fujinaga, J. P. Icenogle, T. Kahn, N. Kiviat, W. Lancaster, N. P. Mavromara, S. Mitrani-Rosenbaum, B. Norrild, M. R. Pillai, J. Stoerker, K. Syrjaenen, S. Syrjaenen, S.-K. Tay, L. L. Villa, C. M. Wheeler, A.-L. Williamson, and H.-U. Bernard. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 67:6413-6423.
35. Ho, L., S. Y. Chan, V. Chow, T. Chong, S. K. Tay, L. L. Villa, and H. U. Bernard. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J. Clin. Microbiol. 29:1765-1772.
36. Ho, L., S. K. Tay, S. Y. Chan, and H. U. Bernard. 1993. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J. Infect. Dis. 168:803-809.
37. Hsieh, C. H., Y. P. Tsao, C. H. Wang, C. P. Han, J. L. Chang, J. Y. Lee, and S. L. Chen. 2000. Sequence variants and functional analysis of human papillomavirus type 16 E5 gene in clinical specimens. Arch. Virol. 145:2273-2284.
38. Huelsenbeck, J. P., and F. Ronquist. 2001. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17:754-755.
39. Hughes, A. L., K. Westover, J. da Silva, D. H. O'Connor, and D. I. Watkins. 2001. Simultaneous positive and purifying selection on overlapping reading frames of the tat and vpr genes of simian immunodeficiency virus. J. Virol. 75:7966-7972.
40. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:4129-4135.
41. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1994. E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. Cold Spring Harbor Symp. Quant. Biol. 59:237-245.
42. Icenogle, J. P., P. Sathya, D. L. Miller, R. A. Tucker, and W. E. Rawls. 1991. Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology 184: 101-107.
43. International Agency for Research on Cancer. 1995. Monographs on the evaluation of carcinogenic risks to humans, vol. 64. Human papillomaviruses, International Agency for Research on Cancer, Lyon, France.
44. Konya, J., C. Eklund, V. af Geijersstam, F. Yuan, G. Stuber, and J. Dillner. 1997. Identification of a cytotoxic T-lymphocyte epitope in the human papillomavirus type 16 E2 protein. J. Gen. Virol. 78:2615-2620.
45. Li, W.-H. 1997. Molecular evolution. Sinauer, Sunderland, Mass.
46. Londesborough, P., L. Ho, G. Terry, J. Cuzick, C. Wheeler, and A. Singer. 1996. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int. J. Cancer 69:364-368.
47. Lundberg, K. S., D. D. Shoemaker, M. W. Adams, J. M. Short, J. A. Sorge, and E. J. Mathur. 1991. High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus. Gene 108:1-6.
48. Mizokami, M., E. Orito, K. Ohba, K. Ikeo, J. Y. Lau, and T. Gojobori. 1997. Constrained evolution with respect to gene overlap of hepatitis B virus. J. Mol. Evol. 44(Suppl. 1):S83-S90.
49. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
50. Myers, G., H. Delius, J. Icenogle, H. U. Bernard, M. Favre, M. van Ranst, and C. M. Wheeler. 1997. Human papillomaviruses 1997: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, N.Mex.
51. Nielsen, R., and Z. Yang. 1998. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929-936.
52. Palefsky, J. M., H. Minkoff, L. A. Kalish, A. Levine, H. S. Sacks, P. Garcia, M. Young, S. Melnick, P. Miotti, and R. Burk. 1999. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J. Natl. Cancer Inst. 91:226-236.
53. Picconi, M. A., L. V. Alonio, L. Sichero, V. Mbayed, L. L. Villa, J. Gronda, R. Campos, and A. Teyssie. 2003. Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J. Med. Virol. 69:546-552.
54. Posada, D., and K. A. Crandall. 1998. MODELTEST: testing the model of DNA substitution. Bioinformatics 14:817-818.
55. Storey, A., M. Thomas, A. Kalita, C. Harwood, D. Gardiol, F. Mantovani, J. Breuer, I. M. Leigh, G. Matlashewski, and L. Banks. 1998. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393:229-234.
56. Straight, S. W., B. Herman, and D. J. McCance. 1995. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol. 69:3185-3192.
57. Swofford, D. L. 1998. PAUP*. Phylogenetic analysis using parsimony (*and other methods), version 4. Sinauer Associates, Sunderland, Mass.
58. Terai, M., and R. D. Burk. 2001. Characterization of a novel genital human papillomavirus by overlapping PCR: candHPV86 identified in cervicovaginal cells of a woman with cervical neoplasia. J. Gen. Virol. 82:2035-2040.
59. Terai, M., and R. D. Burk. 2001. Complete nucleotide sequence and analysis of a novel human papillomavirus (HPV 84) genome cloned by an overlapping PCR method. Virology 279:109-115.
60. Terry, G., L. Ho, and J. Cuzick. 1997. Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type. Int. J. Cancer 73:651-655.
61. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
62. Tornesello, M. L., F. M. Buonaguro, A. Meglio, L. Buonaguro, E. Beth-Giraldo, and G. Giraldo. 1997. Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J. Gen. Virol. 78:2199-2208.
63. van Duin, M., P. J. Snijders, M. T. Vossen, E. Klaassen, F. Voorhorst, R. H. Verheijen, T. J. Helmerhorst, C. J. Meijer, and J. M. Walboomers. 2000. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J. Gen. Virol. 81:317-325.
64. Veress, G., K. Szarka, X. P. Dong, L. Gergely, and H. Pfister. 1999. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J. Gen. Virol. 80:1035-1043.
65. Villa, L. L., L. Sichero, P. Rahal, O. Caballero, A. Ferenczy, T. Rohan, and E. L. Franco. 2000. Molecular variants of human papillomavirus types 15 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 81:2959-2968.
66. Watts, K. J., C. H. Thompson, Y. E. Cossart, and B. R. Rose. 2002. Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. Int. J. Cancer 97:868-874.
67. Xi, L. F., L. A. Koutsky, D. A. Galloway, J. Kuypers, J. P. Hughes, C. M. Wheeler, K. K. Holmes, and N. B. Kiviat. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 89:796-802.
68. Yamada, T., M. M. Manos, J. Peto, C. E. Greer, N. Munoz, F. X. Bosch, and C. M. Wheeler. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71:2463-2472.
69. Yamada, T., C. M. Wheeler, A. L. Halpern, A. C. Stewart, A. Hildesheim, and S. A. Jenison. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 69:7743-7753.
70. Yang, Z. 1997. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13:555-556.
71. Yang, Z., N. Goldman, and A. Friday. 1994. Comparison of models for nucleotide substitution used in maximum-likelihood phylogenetic estimation. Mol. Biol. Evol. 11:316-324.
72. Yang, Z., R. Nielsen, N. Goldman, and A. M. Pedersen. 2000. Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155:431-449.
73. Yang, Z., R. Nielsen, and M. Hasegawa. 1998. Models of amino acid substitution and applications to mitochondrial protein evolution. Mol. Biol. Evol. 15:1600-1611.
74. Yang, Z., and W. J. Swanson. 2002. Codon-substitution models to detect adaptive evolution that account for heterogeneous selective pressures among site classes. Mol. Biol. Evol. 19:49-57.
75. Zehbe, I., J. Mytilineos, I. Wikstrom, R. Henriksen, L. Edler, and M. Tommasino. 2003. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum. Immunol. 64:538-542.
76. Zehbe, I., R. Tachezy, J. Mytilineos, G. Voglino, I. Mikyskova, H. Delius, A. Marongiu, L. Gissmann, E. Wilander, and M. Tommasino. 2001. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int. J. Cancer 94:711-716.
77. Zehbe, I., G. Voglino, H. Delius, E. Wilander, and M. Tommasino. 1998. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352:1441-1442.